We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+514.19%
AUM
$4.39B
AUM Growth
+$118M
Cap. Flow
-$190M
Cap. Flow %
-4.31%
Top 10 Hldgs %
15.83%
Holding
1,464
New
104
Increased
519
Reduced
644
Closed
116

Sector Composition

Rank Sector Weight
1 Miscellaneous 23.21%
2 Technology 15.67%
3 Healthcare 11.79%
4 Financials 11.2%
5 Industrials 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARES icon
901
Ares Management
ARES
$28.3B
$505K 0.01%
7,372
+667
+10% +$48.1K
CRAK icon
902
VanEck Oil Refiners ETF
CRAK
$533M
$502K 0.01%
+16,103
New +$498K
FISV
903
Fiserv Inc
FISV
$26.3B
$500K 0.01%
4,952
+339
+7% +$33.8K
HTZ icon
904
Hertz
HTZ
$670M
$500K 0.01%
32,475
-19,681
-38% -$331K
SLG icon
905
SL Green Realty
SLG
$3.67B
$500K 0.01%
14,814
-1,922
-11% -$73.1K
SNY icon
906
Sanofi
SNY
$102B
$499K 0.01%
10,302
+53
+0.5% +$2.33K
OXY.WS icon
907
Occidental Petroleum Corp Warrants
OXY.WS
$35.2B
$499K 0.01%
12,100
-706
-6% -$32.6K
IBDP
908
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
$496K 0.01%
+20,300
New +$495K
PWV icon
909
Invesco Large Cap Value ETF
PWV
$1.86B
$495K 0.01%
10,521
DBMF icon
910
iMGP DBi Managed Futures Strategy ETF
DBMF
$4.31B
$495K 0.01%
16,996
-520
-3% -$16.9K
TEAM icon
911
Atlassian
TEAM
$48.2B
$495K 0.01%
3,843
-266
-6% -$42.3K
FTHY
912
First Trust High Yield Opportunities 2027 Term Fund
FTHY
$478M
$493K 0.01%
36,568
-455
-1% -$6.31K
PWB icon
913
Invesco Large Cap Growth ETF
PWB
$2.45B
$493K 0.01%
8,250
-3
-0% -$182
IBDQ
914
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
$492K 0.01%
+20,224
New +$490K
LDOS icon
915
Leidos
LDOS
$16.2B
$491K 0.01%
4,664
PRN icon
916
Invesco Dorsey Wright Industrials Momentum ETF
PRN
$357M
$489K 0.01%
5,661
+2,196
+63% +$192K
BTI icon
917
British American Tobacco
BTI
$121B
$488K 0.01%
12,195
-234
-2% -$9.19K
OEC icon
918
Orion
OEC
$325M
$487K 0.01%
27,350
-500
-2% -$8.41K
REGL icon
919
ProShares S&P MidCap 400 Dividend Aristocrats ETF
REGL
$1.71B
$485K 0.01%
6,774
+357
+6% +$25.3K
KR icon
920
Kroger
KR
$36.4B
$482K 0.01%
10,814
-208
-2% -$9.56K
CC icon
921
Chemours
CC
$2.17B
$479K 0.01%
15,630
-500
-3% -$15K
NWN icon
922
Northwest Natural Holdings
NWN
$2.05B
$478K 0.01%
10,050
ADMA icon
923
ADMA Biologics
ADMA
$1.99B
$477K 0.01%
122,825
-77,500
-39% -$239K
CCJ icon
924
Cameco
CCJ
$39.6B
$474K 0.01%
20,888
+4,242
+25% +$99.8K
SRPT icon
925
Sarepta Therapeutics
SRPT
$2.09B
$473K 0.01%
3,650
-250
-6% -$29K

Similar funds

Oppenheimer & Co's Q4 2022 Portfolio in Review

As of Q4 2022, Oppenheimer & Co held 1,464 positions worth $4.39B, up 2.8% from $4.27B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Oppenheimer & Co withdrew a net $190M in Q4 2022, closing 116 positions and reducing 644 holdings. Its most notable exit was State Street SPDR Portfolio Mortgage Backed Bond ETF, an estimated $8.22M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, up from 23% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Oppenheimer & Co opened a new position in State Street SPDR Portfolio S&P 500 Value ETF worth $5.18M.

  • Oppenheimer & Co's largest Q4 2022 buy was State Street SPDR Portfolio S&P 500 Value ETF: 133,272 shares worth $5.18M.
  • Oppenheimer & Co added most to iShares Treasury Floating Rate Bond ETF in Q4 2022, an estimated $5.9M increase.
  • Oppenheimer & Co's biggest Q4 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $22.8M.
  • Oppenheimer & Co fully exited State Street SPDR Portfolio Mortgage Backed Bond ETF in Q4 2022, selling an estimated $8.22M.
  • Oppenheimer & Co's ten largest holdings make up 16% of its $4.39B portfolio in Q4 2022.
  • Oppenheimer & Co opened 104 new positions and closed 116 in Q4 2022.
  • Oppenheimer & Co's portfolio value rose 2.8% quarter-over-quarter to $4.39B.

Based on Oppenheimer & Co's 13F filing for Q4 2022, filed 8 Feb 2023.